Osmond Foundation

Osmond Foundation is a Swedish non-profit organization founded to support research and education in the field of psychedelic science.

Osmond Foundation

Osmond was founded in 2020 in order to raise and distribute funds for psychedelic research, educate the public on psychedelic research and provide regulatory expertise and GMP drug distribution through its parent company, Osmond Labs. The Foundation is currently sponsoring the first-ever clinical trial with psilocybin in Sweden.

“Osmond Foundation promotes understanding of psychedelic substances through clinical research, education of healthcare professionals and the general public, combined with information about risks and opportunities when using psychedelic substances, and aims to contribute to the development of care interventions related to psychedelic substances.”